What is the risk of Reye syndrome with nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen in children with viral infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Reye Syndrome with NSAIDs in Children with Viral Infections

Ibuprofen and other non-aspirin NSAIDs do not carry a risk of Reye syndrome in children with viral infections, while aspirin (acetylsalicylic acid) has a well-established association with Reye syndrome and should be avoided in children and adolescents with viral illnesses. 1, 2, 3

Understanding Reye Syndrome

  • Reye syndrome is a rare but potentially fatal biphasic illness characterized by acute encephalopathy and fatty infiltration of the liver that typically occurs following a viral illness (particularly influenza or varicella) 4
  • The syndrome manifests with protracted vomiting and neurologic changes that typically begin 3-5 days after the viral prodrome, just when the child appears to be recovering 4
  • Mortality rates from Reye syndrome can be as high as 30-40% due to brainstem dysfunction 5

Aspirin and Reye Syndrome Connection

  • There is a well-established association between aspirin use during viral illnesses and the development of Reye syndrome in children and adolescents under 18 years of age 6
  • Since 1986, the FDA has required warning labels on all aspirin products regarding this association 4
  • The incidence of Reye syndrome has decreased dramatically since public awareness campaigns about avoiding aspirin in children with febrile illnesses began 4, 3
  • The risk of Reye syndrome appears to decrease with age, becoming extremely rare by late adolescence 3

NSAIDs and Reye Syndrome

  • Non-aspirin NSAIDs such as ibuprofen have not been associated with Reye syndrome 3, 7
  • The CDC and other health authorities specifically recommend avoiding aspirin in children with viral illnesses, but do not extend this warning to other NSAIDs 1, 2
  • For relief of fever in children with suspected viral illnesses, other antipyretic medications such as acetaminophen or non-aspirin NSAIDs are recommended instead of aspirin 1

Clinical Recommendations

  • Acetaminophen and ibuprofen are the preferred antipyretics for children with fever or viral syndromes 7
  • Children aged <4 years should not receive over-the-counter cold medications without consulting a healthcare provider first 1
  • Aspirin use in children should be limited to specific conditions where it has proven benefit, such as Kawasaki disease and juvenile arthritis 3
  • In Kawasaki disease, where aspirin is indicated, children should receive annual influenza vaccination if on long-term aspirin therapy 1
  • Parents of children on aspirin therapy should be instructed to contact their physician promptly if the child develops symptoms of or is exposed to influenza or varicella 1

Special Considerations

  • For children with Kawasaki disease who require aspirin but are exposed to influenza or varicella, some physicians substitute another antiplatelet medication for aspirin temporarily 1
  • Children and teenagers (6 months-18 years) receiving long-term aspirin therapy are considered a high-risk group for influenza complications and should receive annual influenza vaccination 1
  • The main risk to children taking NSAIDs like ibuprofen is dosage errors resulting in overdose, not Reye syndrome 1

In conclusion, while aspirin should be avoided in children with viral illnesses due to the risk of Reye syndrome, non-aspirin NSAIDs like ibuprofen do not carry this risk and can be safely used as antipyretics in children with appropriate dosing.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antipyretic Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Reye's syndrome: an update.

The Nurse practitioner, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.